Log-in / Create Account  
Session Information
2008 BIO International Convention
Click here to go to the previous page
Co-Development Alliances: Taking Collaboration to a New Level
Track : Business Development
Program Code: 265
Date: Wednesday, June 18, 2008
Time: 2:00 PM to 3:30 PM  EST
Location: 33ABC
CHAIR :
Mark Edwards, Managing Director , Recombinant Capital
SPEAKER (S):
Donna Litvinas, Executive Director, Corporate Licensing , Merck & Co, Inc
Stuart Mackey, Executive Director Licensing , Amgen
Richard Pascoe, SVP and Chief Commercial Officer , ARIAD Pharmaceuticals, Inc
Richard Van Duyne, Head of Global Business Development , Daiichi Sankyo Group
Description
Recent alliances for late-stage compounds have broken through traditional barriers. These include deal economics, joint responsibility for development and concurrent funding of multiple indications. This session will review several of the breakthrough deals of 2007.

Objective1: Prepare for the main risks and challenges presented by emerging markets.

Objective2: Understand actionable best practices and insights to help build organizational capabilities and improve deal processes.

Objective3: Learn from other industries what contributes to success and failure in emerging markets transactions.



Streaming Audio with
PowerPoint Slides
(Code: 265)
  
This session is a part of:
2008 BIO International Convention Complete Session Set
Business Development Track